Eli Lilly
1876
FOUNDED
PUBLIC
STATUS
35K-40K
EMPLOYEES
LLY
STOCK SYMBOL
80
INVESTMENTS
$139.07
SHARE PRICE
(As of Friday Closing)
Description
Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NYS
Primary Office
- Lilly Corporate Center
- Indianapolis, IN 46285
- United States
+1 (317) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Eli Lilly’s full profile, request a free trial.
Eli Lilly Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $101.36 - $142.25 | $134B | $141.21 | $8.37 | 3.36M | 960M |
Eli Lilly Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 121,962,767 | 127,299,871 | 99,590,359 | 86,343,992 |
| Revenue | 24,905,500 | 24,555,700 | 22,871,300 | 21,222,100 |
| EBITDA | 6,169,200 | 5,515,500 | 3,822,400 | 4,947,100 |
| Net Income | 7,947,700 | 3,232,000 | (204,100) | 2,737,600 |
| Total Assets | 37,893,100 | 43,908,400 | 44,981,000 | 38,805,900 |
| Total Debt | 15,710,500 | 12,770,900 | 13,647,100 | 10,305,200 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Eli Lilly Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Eli Lilly‘s full profile, request access.
Request full access to PitchBookEli Lilly Competitors (33)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lundbeck | Corporation | Valby, Denmark | 0000 | |||
| 000 000000 00000 | Private Debt Financed | Bresso, Italy | 0000 | 000.00 | 000000000 | 000.00 |
| 00000000 000000000 | Corporation | West Conshohocken, PA | 00 | 000.00 | 000000 - 000 | 000.00 |
| 000000 | Formerly VC-backed | Cambridge, MA | 0000 | 000.00 | 00000000000 | 000.00 |
| 000000 00000000 | Formerly VC-backed | Foster City, CA | 00000 | 00.000 | 000000000 | 00.000 |
Eli Lilly Investments & Acquisitions (80)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 | 10-Jan-2020 | 000000000000000000 | 00.00 | Pharmaceuticals | 000000 0000000 |
| 000 000000 | 06-Jan-2020 | 00000 00000 00 | 0000 | Biotechnology | 000000 00000 |
| 0000000 0000000000 | 13-Nov-2019 | 00000 00000 00 | 00000 | Drug Discovery | |
| 0000000 0000000000 | 22-Apr-2019 | 000000000 | 0000 | Drug Discovery | 000000 00000 |
| Loxo Oncology | 15-Feb-2019 | Merger/Acquisition | 000 | Pharmaceuticals | 00000 00000 |
Eli Lilly Exits (24)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000000 | 13-Nov-2018 | 00000 00000 00 | 0000 | Completed |
|
| 0000000 | 25-Jul-2018 | 00000 00000 00 | 00000 | Completed |
|
| 0000000 | 19-Dec-2017 | 000000000 | 000 | Completed |
|
| 000000 000000 | 27-Jan-2015 | 000 | 000.00 | Completed |
|
| Zosano Pharma | 19-Aug-2010 | Later Stage VC | 00.00 | Completed |
|
Eli Lilly Subsidiaries (8)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Loxo Oncology | Acquirer | Stamford, CT | 2013 |
| 0000 00000000000 | Biotechnology | Redwood City, CA | 0000 |
| 0000000 000000000 | Biotechnology | Montreal, Canada | 0000 |
| 0000000 0000000000 | Pharmaceuticals | Cambridge, MA | 0000 |
| 00000 0000 0000000 | Venture Capital | Shanghai, China | 0000 |
Eli Lilly Executive Team (66)
34 Former Executives
You’re viewing 5 of 66 executives. Get the full list »Eli Lilly Board Members (12)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 00000 00000 | Eli Lilly | Chief Executive Officer & Chairman | 000 0000 | |
| 00000 000000 | Self | Chairman, Directors and Corporate Governance Committee | 000 0000 | |
| 0000000 000 | Self | Board Member | 000 0000 | |
| 000000 0000000 | Self | Board Member | 000 0000 | |
| 0000 0000000 | Self | Board Member | 000 0000 |
3 Former Board Members
You’re viewing 5 of 12 board members. Get the full list »